News
21/3/2013

IMIM: A step forward in the treatment of chronic urticaria

IMIM: A step forward in the treatment of chronic urticaria


News from IMIM-Hospital del Mar


An international study involving Dr. Ana Giménez Arnau, a dermatologist at the Hospital del Mar and researcher at the IMIM has concluded that a drug normally used to treat severe bronchial asthma caused by allergies (Omalizumab) rapidly eliminates the symptoms of spontaneous chronic urticaria, a development that it is expected will significantly improve the quality of life of chronic urticaria sufferers.

The research, which has consisted of an international Phase III clinical trial conducted across several research centres, has run for 7 months and involved 323 patients from different countries. These patients have an average age of 42 and for the most part are women (76%), a description that accurately reflects the profile of patients with chronic urticaria.

More information:

IMIM press release

Nota de premsa (in Catalan)